TherapeuticsMD (TXMD) EBIT Margin Growth (1y) (2012 - 2026)
TherapeuticsMD (TXMD) EBIT Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | -2,090.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,090.00 |
| Mar 31, 2026 | 22,609.00 |
| Dec 31, 2025 | -7,605.00 |
| Sep 30, 2025 | 9,736.00 |
| Jun 30, 2025 | 111,888.00 |
| Mar 31, 2025 | 3,890.00 |
| Dec 31, 2024 | 24,575.00 |
| Sep 30, 2024 | 313,797.00 |
| Jun 30, 2024 | -62,621.00 |
| Mar 31, 2024 | 27,625.00 |
| Dec 31, 2023 | -41,415.00 |
| Sep 30, 2023 | 75,613.00 |
| Jun 30, 2023 | 370,358.00 |
| Mar 31, 2023 | 193,084.00 |
| Dec 31, 2022 | 26,014.00 |
| Sep 30, 2022 | -394,428.00 |
| Jun 30, 2022 | -411,631.00 |
| Mar 31, 2022 | -242,457.00 |
| Dec 31, 2021 | -3,621.00 |
| Sep 30, 2021 | -2,801.00 |